Outcomes of refractory or relapsed DNMT3A^+ cytogenetically normal acute myeloid leukemia patients receiving the therapy including decitabine conbined with CAG or CAG-like regimen

Outcomes of refractory or relapsed DNMT3A^+ cytogenetically normal acute myeloid leukemia patients receiving the therapy including decitabine conbined with CAG or CAG-like regimen

原文传递

导出

摘要 Objective To study clinical characteristics of refractory or relapsed DNMT3A+cytogenetically normal acute myeloid leukemia(CN-AML)patients,and to explore the overall response rate(ORR)and side effects of these patients followed the therapy including decitabine

作者徐妍珺

机构地区 Dept Hematol

出处《China Medical Abstracts(Internal Medicine)》 2016年第1期54-55,共2页 中国医学文摘（内科学分册（英文版）

关键词 REFRACTORY MYELOID REGIMEN receiving transplant hematopoietic bridged median

分类号 R733.71 [医药卫生—肿瘤]

引文网络
相关文献

1牛会兰（摘）.12057 单用地西他滨治疗imatinib不耐受的CML有效[J].国外药讯,2005(12):21-21.
2英研究称一种新药可降低患者对化疗的抗药性[J].首都医药,2001,8(8):58-58.
3Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukemia： potential contribution to AML proqression[J].Cell Research,2008,18(2):281-289. 被引量：3
4侯健,李荣.对国际骨髓瘤工作组有关复发性多发性骨髓瘤处理推荐的解读[J].临床血液学杂志,2016,29(4):540-543. 被引量：4
5江滨,罗成伟.索拉菲尼治疗复发难治性白血病的I期临床研究[J].循证医学,2011,11(5):273-274. 被引量：4
6段明辉.Efficacy and safety analysis of the combination of cladribine,cytarabine,granulocyte colony stimulating factor( CLAG ) regime in patients with refractory or relapsed acute myeloid leukemia[J].China Medical Abstracts(Internal Medicine),2016,33(3):178-179.
7龚格格.Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma[J].China Medical Abstracts(Internal Medicine),2014,31(2):120-120.
8顾斌.Improved clinical outcome of acute myeloid leukemia with FLT3-ITD mutation treated with sorafenib[J].China Medical Abstracts(Internal Medicine),2016,33(2):56-57.
9李明会.Clinical study of COAD-B regimen in treatment of patients with relapsed /refractory nonHodgkin lymphoma[J].China Medical Abstracts(Internal Medicine),2013,30(4):230-230.
10史沛杰,方建培.嵌合抗原受体T细胞(CAR-T)疗法在常见儿童肿瘤治疗领域中的应用[J].中国小儿血液与肿瘤杂志,2017,22(1):42-45. 被引量：3

China Medical Abstracts(Internal Medicine)

2016年第1期

浏览历史

内容加载中请稍等...

Outcomes of refractory or relapsed DNMT3A^+ cytogenetically normal acute myeloid leukemia patients receiving the therapy including decitabine conbined with CAG or CAG-like regimen

相关作者

相关机构

相关主题

浏览历史